BioXcel Therapeutics, Inc. (BTAI) Insider Trading

Name: BioXcel Therapeutics, Inc. (BTAI) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 14, 2026): Atkins Susan E. (Director): Grant/Award of 17,000 shares.

Get alerted when insiders trade BTAI

Email address

Loading company data...

Beta

Loading company details...

Beta